13/11/2024 Argaam Exclusive
Shares of Nahdi Medical Co. dropped today, Nov. 13, to SAR 122—the lowest price since the company's listing on the Main Market (TASI).
The stock is trading down 1%.
Accordingly, the year-to-date (YTD) losses reached 7% from the listing price of SAR 131. Meanwhile, the losses widened to 42% compared to the highest price since debut at SAR 209.4.
| Open | 123.00 |
| Low | 122.00 |
| High | 124.40 |
| Previous Close | 123.40 |
| Change (3M) | (2.06 %) |
| Change (6M) | (7.63 %) |
| Market Value | 16,172.00 |
| Avg. Volume (3M) | 253,831.12 |
| Avg. Turnover (3M) | 32,709,828.68 |
| Avg. Transaction (3M) | 2,024.25 |
| Change(12M) | (5.95 %) |
| YTD | (9.93 %) |
The company has not made any changes to its capital since its debut in March 2022.
| Date | Type | Capital (M Riyal) | Change (%) |
| 2022 | IPO | 1,300.00 | 0.00% |
| Financial Ratio | Current |
| Market Cap (M Riyal) | 16,172.00 |
| Shares Outstanding ((M)) | 130.00 |
| EPS ( ) (TTM) | 6.41 |
| Book Value (BV) ( Riyal) (Latest announcement) | 18.53 |
| Adjusted P/E (Last12) | 20.20 |
| Price/book | 6.71 |
| Dividend Yield (%) (Last Year) | 4.42 |
| Return on Average Assets (%) (TTM) | 15.09 |
| Return on Average Equity (%) (TTM) | 35.58 |
| Par Value ( Riyal) | 10.00 |
| Enterprise Value (EV) (M) | 15,424.35 |
Fair Average Price
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Buy | Riyad Capital | 123.40 | 150.00 | 21.56 % | |
| Buy | Riyad Capital | 128.40 | 180.00 | 40.19 % | |
| Neutral | SNB Capital | 138.10 | 126.00 | (8.76 %) |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}